Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.120
0.00 (0.03%)
Mar 10, 2026, 9:56 AM EDT - Market open

Bionano Genomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
113286434866585
Market Cap Growth
-22.17%-62.68%-80.07%-49.89%48.00%1276.59%
Enterprise Value
7.0146.8496.68329.82624.23562.93
Last Close Price
1.1217.30113.40876.001794.001848.00
PE Ratio
--0.20-0.28-3.19-11.50-7.90
PS Ratio
0.401.052.3915.6148.1668.81
PB Ratio
0.220.910.901.742.5716.68
P/TBV Ratio
40.080.620.671.692.469.15
P/FCF Ratio
--0.47-0.68-3.39-11.80-15.27
P/OCF Ratio
--0.47-0.69-3.48-12.04-15.27
EV/Sales Ratio
0.241.522.6811.8634.7266.20
EV/EBITDA Ratio
--0.52-0.48-2.71-8.47-15.18
EV/EBIT Ratio
--0.45-0.45-2.50-8.10-14.60
EV/FCF Ratio
--0.68-0.76-2.58-8.51-14.69
Debt / Equity Ratio
0.320.680.800.040.030.47
Debt / EBITDA Ratio
-0.64-0.30-0.39-0.10-0.14-0.44
Debt / FCF Ratio
-0.92-0.39-0.63-0.09-0.15-0.43
Net Debt / Equity Ratio
-0.090.500.13-0.41-0.71-0.63
Net Debt / EBITDA Ratio
0.16-0.20-0.060.833.250.60
Net Debt / FCF Ratio
0.24-0.26-0.100.793.270.58
Asset Turnover
0.370.210.140.080.080.19
Inventory Turnover
1.711.791.011.041.801.70
Quick Ratio
1.140.380.763.3511.704.61
Current Ratio
2.121.061.404.3812.475.23
Return on Equity (ROE)
-90.61%-170.33%-134.56%-45.21%-38.92%-212.46%
Return on Assets (ROA)
-47.23%-71.47%-82.51%-39.03%-32.66%-85.11%
Return on Invested Capital (ROIC)
-72.55%-113.21%-143.35%-96.00%-118.54%-377.41%
Return on Capital Employed (ROCE)
-77.02%-135.30%-111.53%-42.02%-37.91%-139.31%
Earnings Yield
-338.57%-509.42%-360.32%-31.37%-8.70%-12.66%
FCF Yield
-163.85%-213.89%-146.72%-29.50%-8.48%-6.55%
Buyback Yield / Dilution
-201.77%-128.58%-65.20%-5.31%-40.55%-11.39%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q